BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/21/2025 9:22:08 AM | Browse: 84 | Download: 365
 |
Received |
|
2024-09-04 07:47 |
|
Peer-Review Started |
|
2024-09-04 07:47 |
|
First Decision by Editorial Office Director |
|
2024-11-18 09:18 |
|
Return for Revision |
|
2024-11-18 09:18 |
|
Revised |
|
2024-11-30 09:00 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-12-17 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-17 08:48 |
|
Articles in Press |
|
2024-12-17 08:48 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-01-13 01:49 |
|
Publish the Manuscript Online |
|
2025-01-21 09:22 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Incorporation of human β-defensin-1 into immunoliposomes to facilitate targeted autophagy therapy of colon carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ying Huang, Xi-Ye Wang, Jia-Yue Huang and Zheng-Wei Huang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 82104070 |
| Guangdong Universities Keynote Regions Special Funded Project |
No. 2022ZDZX2002 |
|
| Corresponding Author |
Zheng-Wei Huang, Associate Professor, PhD, College of Pharmacy, Jinan University, No. 855 East Xingye Dadao, Panyu District, Guangzhou 511443, Guangdong Province, China. huangzhengw@jnu.edu.cn |
| Key Words |
Human β-defensin-1; Immunoliposomes; Colon cancer; SW620; Autophagy |
| Core Tip |
Nanotechnology is a cost-effective strategy for addressing the druggable properties of proteins. We propose an immunoliposome system that improves the stability, bioavailability and targeting properties of human β-defensin-1 (hBD-1), which will support its clinical translation. Our strategy is highly effective and may lead to positive clinical trials and large-scale production. We consider immunoliposomes to be suitable nanovesicles for enhancing the drug properties of hBD-1 and warrant further basic and translational research. |
| Publish Date |
2025-01-21 09:22 |
| Citation |
Huang Y, Wang XY, Huang JY, Huang ZW. Incorporation of human β-defensin-1 into immunoliposomes to facilitate targeted autophagy therapy of colon carcinoma. World J Clin Oncol 2025; 16(3): 101098 |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i3/101098.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i3.101098 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
